Latest News about TAK
Recent news which mentions TAK
Why Are Seagen Shares Sinking Today?
February 10, 2022
From Benzinga
Take a Leap Into Novavax Stock After Vaccine Sales Start
February 08, 2022
From InvestorPlace
From Benzinga
2 Dirt-Cheap Value Stocks to Buy Now
January 29, 2022
From Motley Fool
3 Healthcare Stocks With High Dividends
January 21, 2022
From Motley Fool
Worldwide Adoption of Novavax Vaccines Makes It a Winner
January 21, 2022
From InvestorPlace
Why Denali Therapeutics Stock Is Sinking This Week
January 13, 2022
From Motley Fool
Why Novavax Stock Is Jumping Today
December 28, 2021
From Motley Fool
FDA Rejects Takeda's Eosinophilic Esophagitis Candidate, Asks For Additional Study
December 22, 2021
From Benzinga
The Daily Biotech Pulse: Allakos Slips Negative Late-Stage Data, Pfizer & Merck Announce Fresh COVID Pill Deal With UK, Regulatory Setback For Takeda
December 22, 2021
From Benzinga
Why Novavax Stock Is Jumping Again Today
December 17, 2021
From Motley Fool
Why Novavax Stock Is Rising Today
December 16, 2021
From Motley Fool
The Daily Biotech Pulse: Calliditas Snags FDA Nod, Novartis to Buy Back $15B In Shares, Valneva Touts Vaccine Data, Immix, Bionomics Debut On Wall Street
December 16, 2021
From Benzinga
Novavax Files For Approval Of Its COVID-19 Vaccine In Japan
December 16, 2021
From Benzinga
3 Stocks That Can Make You Rich in Just a Few Years
December 14, 2021
From InvestorPlace
Comparing Data: Sanofi Vs. Johnson & Johnson Multiple Myeloma Therapies In Newly Diagnosed Patients
December 13, 2021
From Benzinga
7 Best Drug Stocks to Buy for 2022 Without Covid Catalysts
December 07, 2021
From InvestorPlace
2 Ultra-High-Yield Dividend Stocks to Buy as a Hedge Against Inflation
November 30, 2021
From Motley Fool
The Week Ahead In Biotech (Nov. 28-Dec. 4): FDA Decisions For VBI Vaccines, BeyondSpring, CTI Biopharma And Merck Take The Spotlight In A Light Calendar Week
November 28, 2021
From Benzinga
The Daily Biotech Pulse: Kura's Blood Cancer Drug Study Gets Partial Clinical Hold, Takeda FDA Nod, Puma Breast Cancer Treatment Gets Patent Extension
November 24, 2021
From Benzinga
Takeda's Maribavir Scores FDA Approval For Post-Transplant CMV Infection
November 24, 2021
From Benzinga
The Daily Biotech Pulse: Arrowhead Out-Licenses NASH Drug, Tonix Touts COVID-19 Treatment Data, Aadi Jumps On FDA Nod For Rare Tumor Drug
November 23, 2021
From Benzinga
The Week Ahead In Biotech (Nov. 21-Nov. 27): Takeda, Aadi, Fennec FDA Decisions, Earnings In The Spotlight In Holiday-Shortened Week
November 21, 2021
From Benzinga
Takeda, Shattuck Labs Terminate Immuno-Oncology Pact
November 09, 2021
From Benzinga
Here's Why BioCryst Pharmaceuticals Stock Is Losing Ground Today
November 03, 2021
From Motley Fool
Attention Biotech Investors: Mark Your Calendar For November PDUFA Dates
November 02, 2021
From Benzinga
From Benzinga
Earnings Scheduled For October 28, 2021
October 28, 2021
From Benzinga
7 Reasons Why Novavax Is a No-Brainer Pick Over Ocugen
October 21, 2021
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.